IDEXX Laboratories Inc
IDXX469.550USD
+36.900+8.53%
Horário de mercado （ET）Cotações atrasadas em 15 min
38.32BValor de mercado
43.16P/L TTM
Mais detalhes de IDEXX Laboratories Inc Empresa
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.
Informações da empresa
Código da empresaIDXX
Nome da EmpresaIDEXX Laboratories Inc
Data de listagemJun 21, 1991
Fundado em1983
CEOMr. Andrew Emerson
Número de funcionários11000
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 21
EndereçoOne Idexx Drive
CidadeWESTBROOK
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal04092-2041
Telefone12075560300
Sitehttps://www.idexx.com/
Código da empresaIDXX
Data de listagemJun 21, 1991
Fundado em1983
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brian P. Mckeon
Mr. Brian P. Mckeon
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
29.92K
+0.16%
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
--
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
7.88K
--
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
2.74K
+7.24%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
2.40K
--
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+112.86%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brian P. Mckeon
Mr. Brian P. Mckeon
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
29.92K
+0.16%
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
--
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
7.88K
--
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
CAG Diagnostics recurring revenue
3.13B
80.29%
Reference laboratory diagnostic and consulting services
1.34B
34.28%
IDEXX VetLab consumables
1.30B
33.44%
Rapid assay products
359.75M
9.23%
CAG Diagnostics capital - instruments
312.62M
8.02%
Other
-2.54B
-65.27%
Por RegiãoUSD
Nome
Receita
Proporção
United States
2.53B
64.99%
Other Euorpe
196.31M
5.04%
Germany
173.68M
4.46%
Canada
152.88M
3.92%
United Kingdom
134.63M
3.45%
Other
706.82M
18.14%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
CAG Diagnostics recurring revenue
3.13B
80.29%
Reference laboratory diagnostic and consulting services
1.34B
34.28%
IDEXX VetLab consumables
1.30B
33.44%
Rapid assay products
359.75M
9.23%
CAG Diagnostics capital - instruments
312.62M
8.02%
Other
-2.54B
-65.27%
Acionista
Tempo de atualização: sex, 21 de fev
Tempo de atualização: sex, 21 de fev
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
The Vanguard Group, Inc.
11.94%
BlackRock Institutional Trust Company, N.A.
6.57%
State Street Global Advisors (US)
4.49%
Fundsmith LLP
3.29%
Geode Capital Management, L.L.C.
2.83%
Other
70.88%
Estatísticas dos acionistas
Acionista
Proporção
The Vanguard Group, Inc.
11.94%
BlackRock Institutional Trust Company, N.A.
6.57%
State Street Global Advisors (US)
4.49%
Fundsmith LLP
3.29%
Geode Capital Management, L.L.C.
2.83%
Other
70.88%
Tipo
Acionista
Proporção
Investment Advisor
41.57%
Investment Advisor/Hedge Fund
40.96%
Research Firm
3.74%
Pension Fund
2.27%
Hedge Fund
2.19%
Bank and Trust
1.79%
Sovereign Wealth Fund
1.34%
Individual Investor
0.67%
Family Office
0.46%
Other
5.00%
Participação acionária institucional
Tempo de atualização: dom, 19 de jan
Tempo de atualização: dom, 19 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
2216
76.97M
94.97%
-4.38M
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
2023Q2
2157
77.53M
93.40%
-1.56M
2023Q1
2158
77.14M
92.96%
-2.07M
2022Q4
2124
77.44M
93.49%
-2.66M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
9.67M
11.94%
-29.32K
-0.30%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
5.32M
6.57%
-239.97K
-4.31%
Dec 31, 2024
State Street Global Advisors (US)
3.64M
4.49%
+24.20K
+0.67%
Dec 31, 2024
Fundsmith LLP
2.66M
3.29%
-1.31K
-0.05%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.30M
2.83%
+37.73K
+1.67%
Dec 31, 2024
Baron Capital Management, Inc.
2.01M
2.47%
+82.26K
+4.28%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
1.69M
2.09%
+22.74K
+1.36%
Feb 28, 2025
AllianceBernstein L.P.
1.24M
1.53%
-1.58M
-56.02%
Dec 31, 2024
BlackRock Asset Management Ireland Limited
1.13M
1.39%
+36.40K
+3.33%
Dec 31, 2024
Principal Global Investors (Equity)
711.20K
0.88%
-19.27K
-2.64%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
ProShares Pet Care ETF
9.82%
iShares U.S. Medical Devices ETF
3.79%
First Trust Water ETF
3.75%
Acquirers Fund
3.67%
Inspire Tactical Balanced ETF
2.66%
First Trust S&P 500 Economic Moat Index ETF
1.99%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
1.81%
American Century Mid Cap Growth Impact ETF
1.79%
Tema Monopolies and Oligopolies ETF
1.64%
Invesco S&P 500 Equal Weight Health Care ETF
1.58%
Ver Mais
ProShares Pet Care ETF
Proporção9.82%
iShares U.S. Medical Devices ETF
Proporção3.79%
First Trust Water ETF
Proporção3.75%
Acquirers Fund
Proporção3.67%
Inspire Tactical Balanced ETF
Proporção2.66%
First Trust S&P 500 Economic Moat Index ETF
Proporção1.99%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
Proporção1.81%
American Century Mid Cap Growth Impact ETF
Proporção1.79%
Tema Monopolies and Oligopolies ETF
Proporção1.64%
Invesco S&P 500 Equal Weight Health Care ETF
Proporção1.58%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados